Published in Invest New Drugs on April 02, 2014
Combination Radioimmunotherapy Approaches and Quantification of Immuno-PET. Nucl Med Mol Imaging (2016) 0.76
Therapy for metastatic melanoma: the past, present, and future. BMC Med (2012) 1.57
Progress in analytical imaging of the cell by dynamic secondary ion mass spectrometry (SIMS microscopy). Biochim Biophys Acta (2005) 1.55
Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther (2000) 1.44
Update on the current state of melanoma incidence. Dermatol Clin (2012) 1.25
Radiobiologic principles in radionuclide therapy. J Nucl Med (2005) 1.23
Amelanotic melanoma: the great masquerader. J Am Acad Dermatol (2000) 1.23
High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma. Int J Cancer (2002) 1.17
Weak base permeability characteristics influence the intracellular sequestration site in the multidrug-resistant human leukemic cell line HL-60. J Biol Chem (2004) 1.12
Current status of cancer therapy with radiolabeled monoclonal antibody. Ann Nucl Med (2005) 0.94
Radioimmunotherapy for B-cell lymphoma: Y90 ibritumomab tiuxetan and I(131) tositumomab. Oncogene (2007) 0.94
Cardiac applications of 123I-mIBG imaging. Semin Nucl Med (2011) 0.93
Peptide-targeted radionuclide therapy for melanoma. Crit Rev Oncol Hematol (2008) 0.93
Relative therapeutic efficacy of (125)I- and (131)I-labeled monoclonal antibody A33 in a human colon cancer xenograft. J Nucl Med (2001) 0.93
Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis. J Nucl Med (2009) 0.91
Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma. Cancer Res (2010) 0.88
Targeting melanoma with 211At/131I-methylene blue: preclinical and clinical experience. Hybridoma (1999) 0.86
Influence of melanosome dynamics on melanoma drug sensitivity. J Natl Cancer Inst (2009) 0.86
Melanin inhibits cytotoxic effects of doxorubicin and daunorubicin in MOLT 4 cells. Pigment Cell Res (2003) 0.86
A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapy. Nucl Med Biol (2006) 0.83
Targeted melanoma imaging and therapy with radiolabeled alpha-melanocyte stimulating hormone peptide analogues. G Ital Dermatol Venereol (2010) 0.82
Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma. Bioorg Med Chem (2008) 0.82
Meeting report from the 2011 International Melanoma Congress, Tampa, Florida. Pigment Cell Melanoma Res (2011) 0.81
Detectability of liver metastases in malignant melanoma: prospective comparison of magnetic resonance imaging and positron emission tomography. Eur J Radiol (2005) 0.80
Anti-melanoma efficacy of internal radionuclide therapy in relation to melanin target distribution. Pigment Cell Melanoma Res (2010) 0.79
Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using 125I, an Auger electron emitter. Invest New Drugs (2010) 0.79
Targeted radionuclide therapy of melanoma: anti-tumoural efficacy studies of a new 131I labelled potential agent. Int J Cancer (2009) 0.79
Radiation dose profile in 125I brachytherapy: an 8-year review. Radiat Prot Dosimetry (2004) 0.77
Alkylating benzamides with melanoma cytotoxicity: experimental chemotherapy in a mouse melanoma model. Melanoma Res (2006) 0.77
MSH radiopeptides for targeting melanoma metastases. Adv Exp Med Biol (2010) 0.76
Role of acidic cell organelles in the higher nonmelanoma retention of melanoma markers based on N-(2-dialkylaminoethyl)benzamides and the cytotoxicity of alkylating benzamides. Melanoma Res (2007) 0.75
Mammalian heart renewal by pre-existing cardiomyocytes. Nature (2012) 5.56
Progress in analytical imaging of the cell by dynamic secondary ion mass spectrometry (SIMS microscopy). Biochim Biophys Acta (2005) 1.55
The free fatty acid receptor G protein-coupled receptor 40 (GPR40) protects from bone loss through inhibition of osteoclast differentiation. J Biol Chem (2013) 1.49
Gigantism in unique biogenic magnetite at the Paleocene-Eocene Thermal Maximum. Proc Natl Acad Sci U S A (2008) 1.47
Simultaneous analysis of microbial identity and function using NanoSIMS. Environ Microbiol (2007) 1.47
Brief intraperitoneal radioimmunotherapy of small peritoneal carcinomatosis using high activities of noninternalizing 125I-labeled monoclonal antibodies. J Nucl Med (2010) 1.45
A man who brought the war home with him. Lancet (2008) 1.40
Desulfovibrio magneticus RS-1 contains an iron- and phosphorus-rich organelle distinct from its bullet-shaped magnetosomes. Proc Natl Acad Sci U S A (2010) 1.15
Mycobacterium tuberculosis nitrogen assimilation and host colonization require aspartate. Nat Chem Biol (2013) 1.08
Radiation-induced DNA damage: formation, measurement, and biochemical features. J Environ Pathol Toxicol Oncol (2004) 1.08
Microchemical imaging of iodine distribution in the brown alga Laminaria digitata suggests a new mechanism for its accumulation. J Biol Inorg Chem (2007) 1.03
Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma. Cancer Res (2009) 1.01
HO-1-mediated macroautophagy: a mechanism for unregulated iron deposition in aging and degenerating neural tissues. J Neurochem (2009) 1.01
Assessment of oxidative base damage to isolated and cellular DNA by HPLC-MS/MS measurement. Free Radic Biol Med (2002) 1.00
Intracellular precipitation of hydroxyapatite mineral and implications for pathologic calcification. J Struct Biol (2008) 0.99
Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice. Neurobiol Aging (2007) 0.99
Unregulated brain iron deposition in transgenic mice over-expressing HMOX1 in the astrocytic compartment. J Neurochem (2012) 0.98
Quantitative HRMAS proton total correlation spectroscopy applied to cultured melanoma cells treated by chloroethyl nitrosourea: demonstration of phospholipid metabolism alterations. Magn Reson Med (2003) 0.96
Stable tumor vessel normalization with pO₂ increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment. J Mol Med (Berl) (2013) 0.94
Minor contribution of direct ionization to DNA base damage inducedby heavy ions. Int J Radiat Biol (2006) 0.94
Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: normal versus thin. Am J Kidney Dis (2003) 0.93
Proteomic studies of B16 lines: involvement of annexin A1 in melanoma dissemination. Biochim Biophys Acta (2008) 0.93
Noninternalizing monoclonal antibodies are suitable candidates for 125I radioimmunotherapy of small-volume peritoneal carcinomatosis. J Nucl Med (2009) 0.91
Members of the uncultured bacterial candidate division WWE1 are implicated in anaerobic digestion of cellulose. Microbiologyopen (2014) 0.91
First preclinical imaging of primary cartilage neoplasm and its local recurrence using 99mTc-NTP 15-5 radiotracer. J Nucl Med (2009) 0.90
123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging. Eur J Nucl Med Mol Imaging (2002) 0.89
General overview of radioimmunotherapy of solid tumors. Immunotherapy (2013) 0.89
Modulation of DNA damage by pentoxifylline and alpha-tocopherol in skin fibroblasts exposed to Gamma rays. Radiat Res (2005) 0.89
Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples. Cancer Res (2002) 0.89
Aceruloplasminemia: retinal histopathologic manifestations and iron-mediated melanosome degradation. Arch Ophthalmol (2011) 0.89
Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma, and death. Clin Gastroenterol Hepatol (2005) 0.89
Ultra-structural cell distribution of the melanoma marker iodobenzamide: improved potentiality of SIMS imaging in life sciences. Biomed Eng Online (2004) 0.88
Selective transmigration of monocyte-associated HIV-1 across a human cervical monolayer and its modulation by seminal plasma. AIDS (2012) 0.88
Direct contact of platelets and their released products exert different effects on human dendritic cell maturation. BMC Immunol (2008) 0.88
DNA damage in cultured skin microvascular endothelial cells exposed to gamma rays and treated by the combination pentoxifylline and alpha-tocopherol. Int J Radiat Biol (2006) 0.88
Antiangiogenic and antitumoral activity of phenyl-3-(2-chloroethyl)ureas: a class of soft alkylating agents disrupting microtubules that are unaffected by cell adhesion-mediated drug resistance. Cancer Res (2004) 0.88
Mammalian cells loaded with platinum-containing molecules are sensitized to fast atomic ions. Int J Radiat Biol (2008) 0.87
Longitudinal profiling of articular cartilage degradation in osteoarthritis by high-resolution magic angle spinning 1H NMR spectroscopy: experimental study in the meniscectomized guinea pig model. J Proteome Res (2009) 0.87
Alkylation of beta-tubulin on Glu 198 by a microtubule disrupter. Mol Pharmacol (2005) 0.87
Evaluation of radiolabeled (hetero)aromatic analogues of N-(2-diethylaminoethyl)-4-iodobenzamide for imaging and targeted radionuclide therapy of melanoma. J Med Chem (2008) 0.87
Comparison between internalizing anti-HER2 mAbs and non-internalizing anti-CEA mAbs in alpha-radioimmunotherapy of small volume peritoneal carcinomatosis using 212Pb. PLoS One (2013) 0.87
B16 melanoma secretomes and in vitro invasiveness: syntenin as an invasion modulator. Melanoma Res (2010) 0.86
(123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial. J Nucl Med (2013) 0.86
Slow and fast singlet energy transfers in BODIPY-gallium(III)corrole dyads linked by flexible chains. Inorg Chem (2014) 0.85
First In Vivo SPECT Imaging of Mouse Femorotibial Cartilage Using 99mTc-NTP 15-5. Mol Imaging (2009) 0.85
Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracer. Eur J Nucl Med Mol Imaging (2012) 0.85
Early detection and monitoring of cartilage alteration in the experimental meniscectomised guinea pig model of osteoarthritis by 99mTc-NTP 15-5 scintigraphy. Eur J Nucl Med Mol Imaging (2007) 0.85
Antineoplastic potency of arylchloroethylurea derivatives in murine colon carcinoma. Invest New Drugs (2004) 0.84
Borage and fish oils lifelong supplementation decreases inflammation and improves bone health in a murine model of senile osteoporosis. Bone (2011) 0.84
Apoptosis and p53 are not involved in the anti-tumor efficacy of ¹²⁵I-labeled monoclonal antibodies targeting the cell membrane. Nucl Med Biol (2013) 0.84
Annexin A1 in primary tumors promotes melanoma dissemination. Clin Exp Metastasis (2014) 0.84
Vaccination with human anti-trastuzumab anti-idiotype scFv reverses HER2 immunological tolerance and induces tumor immunity in MMTV.f.huHER2(Fo5) mice. Breast Cancer Res (2011) 0.84
Pomegranate seed oil prevents bone loss in a mice model of osteoporosis, through osteoblastic stimulation, osteoclastic inhibition and decreased inflammatory status. J Nutr Biochem (2013) 0.84
Pomegranate and its derivatives can improve bone health through decreased inflammation and oxidative stress in an animal model of postmenopausal osteoporosis. Eur J Nutr (2014) 0.83
Synthesis, radiofluorination, and in vivo evaluation of novel fluorinated and iodinated radiotracers for PET imaging and targeted radionuclide therapy of melanoma. J Med Chem (2013) 0.83
Reaction-diffusion model of nutrient uptake in a biofilm: theory and experiment. J Theor Biol (2011) 0.83
Iron sources used by the nonpathogenic lactic acid bacterium Lactobacillus sakei as revealed by electron energy loss spectroscopy and secondary-ion mass spectrometry. Appl Environ Microbiol (2009) 0.82
Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanoma. Bioorg Med Chem (2008) 0.82
Synthesis, radiosynthesis, and biological evaluation of new proteasome inhibitors in a tumor targeting approach. J Med Chem (2008) 0.81
In vivo efficacy of melanoma internal radionuclide therapy with a 131I-labelled melanin-targeting heteroarylcarboxamide molecule. Int J Cancer (2013) 0.81
Secondary ion mass spectrometry as a tool for investigating radiopharmaceutical distribution at the cellular level: the example of I-BZA and (14)C-I-BZA. J Nucl Med (2005) 0.81
Design, synthesis, and biological activities of conformationally restricted analogs of primaquine with a 1,10-phenanthroline framework. Bioorg Med Chem Lett (2008) 0.81